ViewRays MRI-guided radiotherapy gains 510(k) approval
The FDA has granted ViewRay’s MRI-guided radiation therapy system 510(k) clearance for non-human research, bringing the system a step closer to the company’s anticipated clinical application.
The ViewRay system was designed to provide continuous soft-tissue imaging during radiation therapy using MRI, which would provide physicians with radiation dose localization, the company said. ViewRay develops radiation therapy technology and is based in Cleveland.
The ViewRay system was designed to provide continuous soft-tissue imaging during radiation therapy using MRI, which would provide physicians with radiation dose localization, the company said. ViewRay develops radiation therapy technology and is based in Cleveland.